These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30228110)

  • 1. Vascular Dysfunction, Oxidative Stress, and Inflammation in Autosomal Dominant Polycystic Kidney Disease.
    Nowak KL; Wang W; Farmer-Bailey H; Gitomer B; Malaczewski M; Klawitter J; Jovanovich A; Chonchol M
    Clin J Am Soc Nephrol; 2018 Oct; 13(10):1493-1501. PubMed ID: 30228110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults with ADPKD: A Randomized Controlled Trial.
    Nowak KL; Farmer-Bailey H; Wang W; You Z; Steele C; Cadnapaphornchai MA; Klawitter J; Patel N; George D; Jovanovich A; Soranno DE; Gitomer B; Chonchol M
    Clin J Am Soc Nephrol; 2022 Feb; 17(2):240-250. PubMed ID: 34907021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineralocorticoid Antagonism and Vascular Function in Early Autosomal Dominant Polycystic Kidney Disease: A Randomized Controlled Trial.
    Nowak KL; Gitomer B; Farmer-Bailey H; Wang W; Malaczewski M; Klawitter J; You Z; George D; Patel N; Jovanovich A; Chonchol M
    Am J Kidney Dis; 2019 Aug; 74(2):213-223. PubMed ID: 30803706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular Dysfunction, Oxidative Stress, and Inflammation in Chronic Kidney Disease.
    Nowak KL; Jovanovich A; Farmer-Bailey H; Bispham N; Struemph T; Malaczewski M; Wang W; Chonchol M
    Kidney360; 2020 Jun; 1(6):501-509. PubMed ID: 33305290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular dysfunction in children and young adults with autosomal dominant polycystic kidney disease.
    Nowak KL; Farmer H; Cadnapaphornchai MA; Gitomer B; Chonchol M
    Nephrol Dial Transplant; 2017 Feb; 32(2):342-347. PubMed ID: 28186577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary flow velocity reserve and carotid intima media thickness in patients with autosomal dominant polycystic kidney disease: from impaired tubules to impaired carotid and coronary arteries.
    Turkmen K; Oflaz H; Uslu B; Cimen AO; Elitok A; Kasikcioglu E; Alisir S; Tufan F; Namli S; Uysal M; Ecder T
    Clin J Am Soc Nephrol; 2008 Jul; 3(4):986-91. PubMed ID: 18354076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Vitamin D Metabolites With Arterial Function in the Hemodialysis Fistula Maturation Study.
    van Ballegooijen AJ; Zelnick L; Hoofnagle AN; Hamburg NM; Robinson-Cohen C; Roy-Chaudhury P; Cheung AK; Shiu YT; de Boer IH; Himmelfarb J; Beck G; Imrey PB; Kusek JW; Kestenbaum B;
    Am J Kidney Dis; 2017 Jun; 69(6):805-814. PubMed ID: 28359657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of endothelial dysfunction and arterial stiffness in patients with early-stage autosomal dominant polycystic kidney disease: A meta-analysis.
    Bellos I; Kontzoglou K; Perrea DN
    Int J Clin Pract; 2021 Apr; 75(4):e13721. PubMed ID: 32946652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional arterial stiffness in central and peripheral arteries is differentially related to endothelial dysfunction assessed by brachial flow-mediated dilation in metabolic syndrome.
    Badhwar S; Chandran DS; Jaryal AK; Narang R; Deepak KK
    Diab Vasc Dis Res; 2018 Mar; 15(2):106-113. PubMed ID: 29283006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral augmentation index and vascular inflammation in autosomal dominant polycystic kidney disease.
    Heffernan KS; Kuvin JT; Sarnak MJ; Perrone RD; Miskulin DC; Rudym D; Chandra P; Karas RH; Menon V
    Nephrol Dial Transplant; 2011 Aug; 26(8):2515-21. PubMed ID: 21292815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow-associated dilatory capacity of the brachial artery is intact in early autosomal dominant polycystic kidney disease.
    Clausen P; Feldt-Rasmussen B; Iversen J; Lange M; Eidemak I; Strandgaard S
    Am J Nephrol; 2006; 26(4):335-9. PubMed ID: 16825759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Association of Fibroblast Growth Factor 23 with Arterial Stiffness and Atherosclerosis in Patients with Autosomal Dominant Polycystic Kidney Disease.
    Coban M; Inci A; Yılmaz U; Asilturk E
    Kidney Blood Press Res; 2018; 43(4):1160-1173. PubMed ID: 30064143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular alterations among young adults with SARS-CoV-2.
    Ratchford SM; Stickford JL; Province VM; Stute N; Augenreich MA; Koontz LK; Bobo LK; Stickford ASL
    Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H404-H410. PubMed ID: 33306450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrovascular Pulsatility Index Is Reduced in Autosomal Dominant Polycystic Kidney Disease.
    Steele CN; Oh ES; Wang W; Farmer-Bailey H; Gitomer BY; Chonchol M; Nowak KL
    Am J Nephrol; 2023; 54(5-6):165-174. PubMed ID: 37231790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease.
    Bruschi M; Granata S; Santucci L; Candiano G; Fabris A; Antonucci N; Petretto A; Bartolucci M; Del Zotto G; Antonini F; Ghiggeri GM; Lupo A; Gambaro G; Zaza G
    Clin J Am Soc Nephrol; 2019 Jun; 14(6):834-843. PubMed ID: 31018934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive assessment of arterial stiffness by pulse-wave velocity correlates with endothelial dysfunction.
    Jadhav UM; Kadam NN
    Indian Heart J; 2005; 57(3):226-32. PubMed ID: 16196179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation, oxidative stress, and insulin resistance in polycystic kidney disease.
    Menon V; Rudym D; Chandra P; Miskulin D; Perrone R; Sarnak M
    Clin J Am Soc Nephrol; 2011 Jan; 6(1):7-13. PubMed ID: 20829421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular stiffness and endothelial dysfunction: Correlations at different levels of blood pressure.
    Figueiredo VN; Yugar-Toledo JC; Martins LC; Martins LB; de Faria AP; de Haro Moraes C; Sierra C; Coca A; Moreno H
    Blood Press; 2012 Feb; 21(1):31-8. PubMed ID: 22029740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial dysfunction and low-grade inflammation are associated with greater arterial stiffness over a 6-year period.
    van Bussel BC; Schouten F; Henry RM; Schalkwijk CG; de Boer MR; Ferreira I; Smulders YM; Twisk JW; Stehouwer CD
    Hypertension; 2011 Oct; 58(4):588-95. PubMed ID: 21859964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure and not uraemia is the major determinant of arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal co-morbidity.
    Lilitkarntakul P; Dhaun N; Melville V; Blackwell S; Talwar DK; Liebman B; Asai T; Pollock J; Goddard J; Webb DJ
    Atherosclerosis; 2011 May; 216(1):217-25. PubMed ID: 21376323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.